| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Sorafenib | CCLE | pan-cancer | AAC | 0.085 | 0.08 |
| mRNA | Epothilone B | FIMM | pan-cancer | AAC | -0.29 | 0.08 |
| mRNA | fluvastatin | CTRPv2 | pan-cancer | AAC | -0.066 | 0.08 |
| mRNA | trifluoperazine | CTRPv2 | pan-cancer | AAC | 0.069 | 0.08 |
| mRNA | BMS-270394 | CTRPv2 | pan-cancer | AAC | 0.066 | 0.09 |
| mRNA | canertinib | CTRPv2 | pan-cancer | AAC | -0.064 | 0.09 |
| mRNA | PHA-793887 | GDSC1000 | pan-cancer | AAC | 0.053 | 0.09 |
| mRNA | COL-3 | CTRPv2 | pan-cancer | AAC | 0.066 | 0.09 |
| mRNA | BMS-195614 | CTRPv2 | pan-cancer | AAC | 0.067 | 0.09 |
| mRNA | AZD-7545 | CTRPv2 | pan-cancer | AAC | 0.064 | 0.09 |